1997
Seroreactivity to hepatitis E virus in areas where the disease is not endemic
Thomas D, Yarbough P, Vlahov D, Tsarev S, Nelson K, Saah A, Purcell R. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. Journal Of Clinical Microbiology 1997, 35: 1244-1247. PMID: 9114415, PMCID: PMC232737, DOI: 10.1128/jcm.35.5.1244-1247.1997.Peer-Reviewed Original ResearchConceptsInjection drug usersHistory of hepatitisVirus antibodiesBlood donorsHigh-risk drug-using practicesHomosexual menHepatitis E virus antibodiesHepatitis E diseaseC virus antibodyHepatitis C antibodyHigh-risk groupHigh-risk populationHigh-risk sexual practicesDrug use practicesHepatitis AE virusC antibodySubclinical infectionB antibodiesE diseaseDrug usersEnzyme immunoassaySerum samplesHomosexual malesInfection
1995
Incidence and Risk Factors for Human T-Lymphotropic Virus Type II Seroconversion Among Injecting Drug Users in Baltimore, Maryland, U.S.A
Vlahov D, Khabbaz R, Cohn S, Galai N, Taylor E, Kaplan J. Incidence and Risk Factors for Human T-Lymphotropic Virus Type II Seroconversion Among Injecting Drug Users in Baltimore, Maryland, U.S.A. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 9: 89-96. PMID: 7712239, DOI: 10.1097/00042560-199505010-00013.Peer-Reviewed Original ResearchConceptsRisk factorsDrug usersEnzyme immunoassayWestern blotHuman T-lymphotropic virusNeedle-sharing practicesRisk factor analysisT-lymphotropic virusMedian lag timeCase-control designALIVE studyRecent serumSeronegative IDUsStudy entryBaseline historyIncidence rateSeroconversionPositive casesSex partnersIDUsHTLVCalendar timeMonthsIncidenceBaseline
1991
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Viscidi R, Hill P, Li S, Cerny E, Vlahov D, Farzadegan H, Halsey N, Kelen G, Quinn T. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 1190-8. PMID: 1941526.Peer-Reviewed Original ResearchConceptsEnzyme immunoassayHTLV-IIAntibody reactivityPeptide enzyme immunoassayHTLV-II infectionEpidemiology of HTLVDifferentiation of HTLVMicrotiter plate enzyme immunoassaysPattern of reactivitySeronegative controlsEmergency departmentEnv peptidesPositive seraViral infectionNeurological diseasesHTLVSynthetic peptidesInfectionDrug abuseMajor envelope proteinEnvEnvelope proteinPatientsSerumAntibodies